Hims & Hers Health, Inc. (NYSE: HIMS) is a telehealth and consumer health company that completed its SPAC merger in January 2021 after combining with Oaktree Acquisition Corp., a blank-check vehicle sponsored by Oaktree Capital Management. The company operates in the digital health and direct-to-consumer wellness sector, offering prescription and over-the-counter treatments across categories including sexual health, hair loss, skincare, and mental health. The June 2023 8-K filing reflects continued public reporting activity as the company advances its post-merger growth strategy. HIMS remains actively traded on the New York Stock Exchange. For full filing history, sponsor data, and deal analytics on HIMS and hundreds of other SPAC transactions, sign up for SpacDesk at spacdesk.com.